<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/rss20.xsl" media="screen"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<atom:link href="http://enantone-effets-secondaires.hautetfort.com/effets_secondaires_france/index.rss" rel="self" type="application/rss+xml" />
<title>Victimes Enantone, Décapeptyl - effets_secondaires_france</title>
<description>Blog de l'association de victimes de tous les analogues agonistes GnRH. Informations sur les effets secondaires.</description>
<link>http://enantone-effets-secondaires.hautetfort.com/effets_secondaires_france/</link>
<lastBuildDate>Sat, 22 Aug 2009 07:43:57 +0200</lastBuildDate>
<generator>HautetFort.com</generator>
<copyright>All Rights Reserved</copyright>
<item>
<guid isPermaLink="true">http://enantone-effets-secondaires.hautetfort.com/archive/2008/01/12/base-de-donnees-theriaque-enantone-decapeptyl-zoladex-effets.html</guid>
<title>Thériaque (base de données): Enantone, Décapeptyl, Zoladex, Synarel, effets secondaires</title>
<link>http://enantone-effets-secondaires.hautetfort.com/archive/2008/01/12/base-de-donnees-theriaque-enantone-decapeptyl-zoladex-effets.html</link>
<author>noreply@hautetfort.com (Prudentia)</author>
<category>Effets secondaires France</category>
<pubDate>Sat, 12 Jan 2008 05:25:00 +0100</pubDate>
<description>
&lt;p style=&quot;margin: 0cm 0cm 0pt&quot; class=&quot;MsoNormal&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;THERIAQUE est la b&lt;/font&gt;&lt;/font&gt;&lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;ase de données du Centre National Hospitalier d'Information sur le Médicament (CNHIM). Elle est&lt;/font&gt; &lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;réservée aux professionnels de santé, il n'y a donc pas d'accès direct.&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;margin: 0cm 0cm 0pt&quot; class=&quot;MsoNormal&quot;&gt;&lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;Page d'accueil: &lt;a href=&quot;http://www.theriaque.org/&quot;&gt;http://www.theriaque.org/&lt;/a&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;margin: 0cm 0cm 0pt&quot; class=&quot;MsoNormal&quot;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&quot;margin: 0cm 0cm 0pt&quot; class=&quot;MsoNormal&quot;&gt;&lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;Les effets indésirables sont les mêmes pour tous les analogues agonistes GnRH (ou LH-RH). A noter qu'il manque ici la rubrique contenant les&amp;nbsp;mises en garde,&amp;nbsp;par exemple celle&amp;nbsp;sur l'apoplexie hypophysaire en cas d'adénome hypophysaire. Les données n'ont pas été actualisées depuis un certain temps, mais Thériaque reste quand même une source un petit peu meilleure que le Vidal (qui est catastrophique en ce qui concerne les analogues agonistes GnRH, mais pas seulement...), et a le mérite d'être en français...&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;margin: 0cm 0cm 0pt&quot; class=&quot;MsoNormal&quot;&gt;&lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;Depuis 2007, les mises en garde figurant dans les notices et les RCP indiquent la possible survenue d'une apoplexie hypophysaire même lorsqu'il n'y a pas d'adénome préexistant de l'hypophyse. Et la possible survenue d'un adénome de l'hypophyse (tumeur bénigne de la glande pituitaire ou hypophyse).&lt;/font&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt; font-family: 'Book Antiqua'&quot;&gt;&quot;&lt;font color=&quot;#008000&quot;&gt;EFFETS INDESIRABLES CLINIQUES&lt;/font&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt; &lt;b&gt;&lt;span style=&quot;font-size: 10pt; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES DE L'ETAT GENERAL&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt; line-height: 150%; font-family: Verdana&quot;&gt;:&amp;nbsp;&lt;/span&gt;&lt;i&gt;&lt;span style=&quot;font-size: 9pt; line-height: 150%; font-family: Verdana&quot;&gt;ASTHENIE, DOULEUR, DYSPNEE, FIEVRE,&amp;nbsp;FRISSON, HYPERSUDATION, LETHARGIE, MALAISE / LIPOTHYMIE, PALPITATIONS&lt;/span&gt;&lt;/i&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES DU SYSTEME NERVEUX&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt; line-height: 150%; font-family: Verdana&quot;&gt;:&lt;/span&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; line-height: 150%; font-family: Verdana&quot;&gt;ACCES MANIAQUE, CAUCHEMAR, CEPHALEE, DEPRESSION, DOULEUR,&lt;span&gt;&amp;nbsp;&lt;/span&gt; FRAGILITE EMOTIONNELLE, HUMEUR (TROUBLE), HYPOESTHESIE, INSOMNIE, IRRITABILITE, MOUVEMENT ANORMAL, PARESTHESIE, SOMMEIL (TROUBLE), SOMNOLENCE DIURNE, VERTIGE / ETOURDISSEMENT&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES DE LA PEAU ET DES APPENDICES&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt; line-height: 150%; font-family: Verdana&quot;&gt;:&lt;/span&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; line-height: 150%; font-family: Verdana&quot;&gt;ACNE, ALOPECIE, BRULURE LOCALE, DOULEUR LOCALE AU POINT D'INJECTION, ECCHYMOSES, ERUPTION CUTANEE, ERYTHEME,&amp;nbsp;HEMATOME, INDURATION, INFLAMMATION LOCALE AU POINT D'INJECTION, NECROSE CUTANEE, OEDEME CUTANE, PILOSITE (MODIFICATION), PRURIT,&amp;nbsp; REACTION LOCALE AU POINT D'INJECTION, SECHERESSE CUTANEE, THROMBOEMBOLIE, THROMBOPHLEBITE, ULCERE CUTANE&amp;nbsp;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 10pt; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES DE LA PEAU ET DES APPENDICES&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size: 7.5pt; line-height: 150%; font-family: Verdana&quot;&gt;:&lt;/span&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; line-height: 150%; font-family: Verdana&quot;&gt;ACNE, ALOPECIE, BRULURE LOCALE, DOULEUR LOCALE AU POINT D'INJECTION, ECCHYMOSES, ERUPTION CUTANEE, ERYTHEME,&amp;nbsp;HEMATOME, INDURATION, INFLAMMATION LOCALE AU POINT D'INJECTION, NECROSE CUTANEE, OEDEME CUTANE, PILOSITE (MODIFICATION), PRURIT,&amp;nbsp; REACTION LOCALE AU POINT D'INJECTION, SECHERESSE CUTANEE, THROMBOEMBOLIE, THROMBOPHLEBITE, ULCERE CUTANE&amp;nbsp;&lt;/span&gt;&lt;/i&gt;&lt;strong&gt;&lt;span style=&quot;font-size: 7.5pt; line-height: 150%; font-family: Verdana&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES DU SYSTEME IMMUNITAIRE&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size: 7.5pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;:&lt;/span&gt;&lt;/b&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;ANAPHYLAXIE, &amp;nbsp;BRONCHOSPASME / ASTHME, &amp;nbsp;CHOC ANAPHYLACTIQUE, ERUPTION CUTANEE,&amp;nbsp; OEDEME DE QUINCKE / ANGIOEDEME,&amp;nbsp; PRURIT,&amp;nbsp; REACTION ALLERGIQUE,&amp;nbsp; URTICAIRE&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;display: none; font-size: 7.5pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES DES ORGANES DES SENS:&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size: 7.5pt; line-height: 150%; font-family: Verdana&quot;&gt;&lt;em&gt;&lt;span style=&quot;display: none; color: black; font-family: Verdana&quot;&gt;ACOUPHENE / BOURDONNEMENT D'OREILLE, HYPERTENSION / HYPERTONIE OCULAIRE,&amp;nbsp; SECHERESSE OCULAIRE,&amp;nbsp; VISION (ALTERATION),&amp;nbsp;&amp;nbsp;VISION FLOUE&lt;/span&gt;&lt;/em&gt;&lt;span style=&quot;display: none; color: black&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES AFFECTANT PLUSIEURS ORGANES:&lt;/span&gt;&lt;/b&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;COMPRESSION MEDULLAIRE,&amp;nbsp; DOULEUR OSSEUSE,&amp;nbsp; DOULEUR TUMORALE,&amp;nbsp; OEDEME DES MEMBRES INFERIEURS,&amp;nbsp; TROUBLE URINAIRE&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES MUSCULO-SQUELETTIQUES:&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size: 7.5pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/b&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;ARTHRALGIE,&amp;nbsp; CRAMPE MUSCULAIRE,&amp;nbsp; DEMINERALISATION OSSEUSE,&amp;nbsp; DORSALGIE,&amp;nbsp; DOULEUR,&amp;nbsp; DOULEUR OSSEUSE,&amp;nbsp; FAIBLESSE MUSCULAIRE,&amp;nbsp; HYPOTONIE MUSCULAIRE,&amp;nbsp; MYALGIE&amp;nbsp;,&amp;nbsp; OSTEOPOROSE&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;span style=&quot;font-size: 10pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;&lt;a target=&quot;body&quot; href=&quot;http://www.theriaque.org/InfoMedicaments/communEI/EINewPart2.cfm?maPersonnalisation=specialite&amp;amp;Element=21265&amp;amp;Nom_Element=ENANTONE%20LP%2011%2C25MG%20PDR%20INJ%20%2B%20NEC&amp;amp;EIDosage=Ther&amp;amp;code_liste=911&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; text-decoration: none; text-underline: none&quot;&gt;TROUBLES GASTRO- INTESTINAUX&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 11pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;:&lt;/span&gt;&lt;span style=&quot;font-size: 7.5pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;&amp;nbsp;&lt;/span&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;AMAIGRISSEMENT,&amp;nbsp; ANOREXIE,&amp;nbsp; CONSTIPATION,&amp;nbsp; DIARRHEE,&amp;nbsp; DYSPEPSIE&amp;nbsp;,&amp;nbsp; ERUCTATION,&amp;nbsp; FLATULENCE / METEORISME,&amp;nbsp; NAUSEE / VOMISSEMENT,&amp;nbsp;&amp;nbsp;PRISE PONDERALE,&amp;nbsp; SECHERESSE BUCCALE&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;span style=&quot;font-size: 10pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;&lt;a target=&quot;body&quot; href=&quot;http://www.theriaque.org/InfoMedicaments/communEI/EINewPart2.cfm?maPersonnalisation=specialite&amp;amp;Element=21265&amp;amp;Nom_Element=ENANTONE%20LP%2011%2C25MG%20PDR%20INJ%20%2B%20NEC&amp;amp;EIDosage=Ther&amp;amp;code_liste=7990&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; text-decoration: none; text-underline: none&quot;&gt;TROUBLES HEPATO-BILIAIRES&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;:&lt;/span&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;ATTEINTE HEPATIQUE&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;span style=&quot;font-size: 10pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;&lt;a target=&quot;body&quot; href=&quot;http://www.theriaque.org/InfoMedicaments/communEI/EINewPart2.cfm?maPersonnalisation=specialite&amp;amp;Element=21265&amp;amp;Nom_Element=ENANTONE%20LP%2011%2C25MG%20PDR%20INJ%20%2B%20NEC&amp;amp;EIDosage=Ther&amp;amp;code_liste=8374,5428&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; text-decoration: none; text-underline: none&quot;&gt;TROUBLES METABOLISME ET NUTRITION&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 11pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;:&lt;/span&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;AUGMENTATION DU VOLUME MAMMAIRE,&amp;nbsp; DIABETE, &lt;a target=&quot;body&quot; href=&quot;http://www.theriaque.org/InfoMedicaments/communEI/EINewPart2.cfm?maPersonnalisation=specialite&amp;amp;Element=21265&amp;amp;Nom_Element=ENANTONE%20LP%2011%2C25MG%20PDR%20INJ%20%2B%20NEC&amp;amp;EIDosage=Ther&amp;amp;code_liste=8374&quot;&gt;&lt;span style=&quot;color: black; text-decoration: none; text-underline: none&quot;&gt;DOULEUR TUMORALE&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;span style=&quot;font-size: 10pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;&lt;a target=&quot;body&quot; href=&quot;http://www.theriaque.org/InfoMedicaments/communEI/EINewPart2.cfm?maPersonnalisation=specialite&amp;amp;Element=21265&amp;amp;Nom_Element=ENANTONE%20LP%2011%2C25MG%20PDR%20INJ%20%2B%20NEC&amp;amp;EIDosage=Ther&amp;amp;code_liste=909&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; text-decoration: none; text-underline: none&quot;&gt;TROUBLES RENAUX ET GENITO-URINAIRES&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 11pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;:&lt;/span&gt;&lt;span style=&quot;font-size: 7.5pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;&amp;nbsp;&lt;/span&gt; &lt;i&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;BOUFFEE VASOMOTRICE&lt;br /&gt;&lt;/span&gt;&lt;/i&gt;&lt;i&gt;&lt;span style=&quot;font-size: 9pt; line-height: 150%; font-family: Verdana&quot;&gt;&lt;a target=&quot;body&quot; href=&quot;http://www.theriaque.org/InfoMedicaments/communEI/EINewPart2.cfm?maPersonnalisation=specialite&amp;amp;Element=21265&amp;amp;Nom_Element=ENANTONE%20LP%2011%2C25MG%20PDR%20INJ%20%2B%20NEC&amp;amp;EIDosage=Ther&amp;amp;code_liste=909&quot;&gt;&lt;/a&gt;&lt;span style=&quot;color: black&quot;&gt;&amp;nbsp;DOULEUR ABDOMINALE,&amp;nbsp; DOULEUR MAMMAIRE,&amp;nbsp; DOULEUR PELVIENNE,&amp;nbsp; DOULEUR TESTICULAIRE,&amp;nbsp; DYSMENORRHEE,&amp;nbsp; DYSPAREUNIE, DYSURIE,&amp;nbsp; ERECTION (TROUBLE),&amp;nbsp; GYNECOMASTIE,&amp;nbsp; HEMORRAGIE URO-GENITALE,&amp;nbsp; HYPERSTIMULATION OVARIENNE,&amp;nbsp; HYPERSUDATION,&amp;nbsp; HYPERTROPHIE OVARIENNE,&amp;nbsp; IMPUISSANCE,&amp;nbsp; LIBIDO (TROUBLE),&amp;nbsp; METRORRAGIE&amp;nbsp;,&amp;nbsp; MICTION (TROUBLE),&amp;nbsp; NYCTURIE,&amp;nbsp; OLIGURIE&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;span style=&quot;font-size: 7.5pt; line-height: 150%; font-family: Verdana&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt; color: green; line-height: 150%; font-family: Verdana&quot;&gt;EFFETS&amp;nbsp; INDESIRABLES&amp;nbsp; PARACLINIQUES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES AFFECTANT PLUSIEURS ORGANES:&lt;/span&gt;&lt;/b&gt; &lt;em&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;HEMATURIE&lt;/span&gt;&lt;/em&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES HEPATO-BILIAIRES:&lt;/span&gt;&lt;/b&gt; &lt;em&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;ALAT (MODIFICATION), ASAT (MODIFICATION)&lt;/span&gt;&lt;/em&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES METABOLISME ET NUTRITION:&lt;/span&gt;&lt;/b&gt; &lt;em&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;DIMINUTION DE TOLERANCE AU GLUCOSE, HYPERCALCEMIE,&lt;/span&gt;&lt;/em&gt;&lt;i&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;&lt;span&gt;&amp;nbsp;&lt;/span&gt; &lt;em&gt;&lt;span style=&quot;font-family: Verdana&quot;&gt;HYPERLIPIDEMIE, HYPERTRIGLYCERIDEMIE&lt;/span&gt;&lt;/em&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;b&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;TROUBLES RENAUX ET GENITO-URINAIRES:&lt;/span&gt;&lt;/b&gt; &lt;em&gt;&lt;span style=&quot;font-size: 9pt; color: black; line-height: 150%; font-family: Verdana&quot;&gt;HEMATURIE&quot;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;
</description>
</item>
</channel>
</rss>